Kesimpta is a prescription medication used for the treatment of relapsing forms of multiple sclerosis. It belongs to a group of medicines called monoclonal antibodies and works by targeting a specific type of immune cell known as B cells.

These B cells are believed to contribute to inflammation and damage in multiple sclerosis. Kesimpta’s active ingredient, kesimpta ofatumumab, binds to these B cells and reduces their number, helping to limit the immune system’s harmful effects in multiple sclerosis. The result is fewer relapses and slower disease progression, which gives patients a greater chance to maintain their quality of life. This has been shown in various clinical studies.

One of the advantages of Kesimpta is that it comes in a prefilled pen or syringe for subcutaneous injection, meaning it can be administered at home after proper training from a healthcare professional. This provides patients with the convenience of self-treatment without frequent hospital visits and ongoing support from their healthcare provider.

On our website, you can find Kesimpta in its standard form: a 20 mg/0.4 mL solution in prefilled pens, each one intended for single use.